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Treatment of obstructive sleep apnea in children
Obstructive sleep apnea (OSA) in children is a frequent disease for 
which optimal diagnostic methods are still being defined. Treatment 
of OSA in children should include providing space, improving cranio-
facial growth, resolving all symptoms, and preventing the development 
of the disease in the adult years. Adenotonsillectomy (T&A) has 
been the treatment of choice and thought to solve young patient’s 
OSA problem, which is not the case for most adults. Recent reports 
showed success rates that vary from 27.2% to 82.9%. Children snoring 
regularly generally have a narrow maxilla compared to children who 
do not snore. The impairment of nasal breathing with increased nasal 
resistance has a well-documented negative impact on early childhood 
maxilla-mandibular development, making the upper airway smaller 
and might lead to adult OSA. Surgery in young children should be 
performed as early as possible to prevent the resulting morphologic 
changes and neurobehavioral, cardiovascular, endocrine, and 
metabolic complications. Close postoperative follow-up to monitor 
for residual disease is equally important. As the proportion of obese 
children has been increasing recently, parents should be informed 
about the weight gain after T&A. Multidisciplinary evaluation of the 
anatomic abnormalities in children with OSA leads to better overall 
treatment outcome. 
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and daytime somnolence, which have contributed to the present 
understanding that the clinical manifestations and treatments for 
OSA are substantially different in children compared with adults. 
The overall prevalence of parent-reported snoring, by any 
definition, in a meta-analysis was 7.45%
4). Although the definition 
and measurement of OSA vary, a recent review of literature
4) 
suggested the prevalence of OSA from 0.1% to 13%, and most 
studies report 1% to 4% diagnosed by varying criteria on diagnostic 
studies. Korean research reported that 4.3% of elementary 
Introduction
Obstructive sleep apnea (OSA), alternative name sleep-disordered 
breathing (SDB), refers to a group of respiratory conditions 
that are exacerbated during sleep due to increased upper airway 
resistance, disruption of ventilation, and sleep discontinuity
1, 2). 
Contemporary descriptions of the condition begin with the report 
of Guilleminault
3) in 1976 on 8 children with OSA accompanied 
by additional symptoms, such as hypertension, hyperactivity, Korean J Pediatr 2010;53(10):872-879 • DOI: 10.3345/kjp.2010.53.10.872    873
school children snore almost every day
5), and the prevalence 
of habitual snoring (>3 per week) was 7.1% among elementary 
school children
6), and the prevalence of habitual snoring and OSA 
among high school children is 11.2% and 0.9% respectively
7).   
OSA occurs at all ages, with the peak prevalence from 2 to 8 years 
of age, when tonsils and adenoids are largest in relation to the 
upper airway size
1, 2 ,8). If unrecognized and untreated, OSAS can 
lead to neurobehavioral, growth, and cardiovascular sequelae in 
childhood
1, 2). Adenoidectomy and/or tonsillectomy (T&A) are 
most often performed as the first-line treatment in childhood OSA
1, 
2). While it is generally believed that T&A is successful in most 
cases, recent reports showed success rates that vary from 27.2% to 
82.9%
9-13). New treatment modalities have been described in the last 
few years for childhood SDB beyond T&A
14-16). The purpose of this 
article is to summarize current knowledge on available treatments 
for OSA in children to improve pediatric OSA management. 
Craniofacial morphological changes secondary to 
upper airway obstruction 
By the age of 4 years the craniofacial skeleton has attained 60% 
of adult size, and by the age of 12 years, it is 90% of adult size
8). 
Craniofacial anomaly results from both genetic and environmental 
determinants. The observation of familial aggregates of SDB
17, 18), 
and that an African American or Far Eastern origin is a risk factor 
for SDB, strongly suggests the importance of genes in linking 
the craniofacial skeleton and SDB
19). However, environmental 
factors are also important determinants of craniofacial growth 
and development. Studies in monkeys and children have shown 
that upper airway obstruction with mouth breathing can induce 
craniofacial anomalies, which can be improved or normalized after 
SDB treatments such T&A
20-22). Children who do not improve 
tend to have a narrower oropharyngeal airspace and mandibular 
retrognathia
23, 24). SDB can induce craniofacial anomalies, which 
likely further increase the risk of SDB. This necessitates the early 
detection and treatment of SDB in children. It is suggested that 
continuation of SDB leads to worsening of the craniofacial pattern 
year by year
25) (Fig. 1).
Treatment of OSA in Children
Treatment of OSA should include providing space for ventilation, 
improvement of cranio-facial growth, improvement all symptoms, 
and preventing the development of adult OSA.
Surgical Treatment
1.  Adenoidectomy and Tonsillectomy 
1)  Indications for T&A 
The indication for T&A in children with adenotonsillar 
hypertrophy is straightforward in the presence of OSA proven by 
polysomnography (PSG) or in snoring children with an abnormal, 
full-night pulse oxymetry recording
1, 2, 26). The American Academy 
of Pediatrics (AAP) Clinical Practice Guidelines state that all 
children should be screened for snoring and recommended PSG 
as the gold standard for diagnosis of OSA because patient history 
and physical examination are poor discriminators of primary 
snoring and OSAS
2). The prevalence of snoring was reported 
to be 6-12%, and the prevalence of OSAS was about 1-3%
4). 
Testing 10% of children is a lot for PSG, but unnecessary surgery 
poses problems such as high cost and suffering in the patient. 
In a survey of the members of American Society of Pediatric 
Otolaryngology, only 10% of children undergoing T&A had 
PSG
27). The recent guidelines
2) that envisage the use of PSG as a 
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Fig. 1. Influence of sleep-disordered breathing on orofacial growth
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reference method to differentiate primary snoring from OSAS are 
inapplicable in clinical practice due to cost of the test and the lack 
of laboratories that study sleep in the pediatric age group
27, 28). Also, 
there is currently no definitive set of PSG criteria that will reliably 
discriminate those children who have OSAS and require treatment
1, 
2, 4, 28-32). Therefore, for otherwise healthy children with a history 
consistent with nighttime snoring; restless sleep; daytime symptoms 
including somnolence, behavior changes, and poor cognitive 
performance; and a physical exam consistent with adenotonsillar 
hypertrophy, with or without witnessed apnea, it is reasonable to 
proceed with T&A without prior PSG
30, 31). Doubt in the diagnosis 
and being categorized as a high-risk individual for surgery are 
the most common indications for PSG
28-30). Preoperative PSG 
is needed when the child has medical comorbidity, age <3 years, 
morbid obesity, small tonsils and adenoids, and history and physical 
findings that do not correlate with the degree of airway obstruction
1, 
2, 28-31) (Table 1).
T&A is generally accepted as the first-line treatment in associated 
medical conditions such as abnormal control of upper airway 
muscles, e.g., cerebral palsy, Down syndrome, and obesity, even 
in the absence of clear adenotonsillar hypertrophy. However, 
persistence or recurrence of snoring and SDB after T&A is also 
common in these conditions
1, 2). 
The PSG diagnosis of OSAS in children is defined as apnea 
hypopnea index (AHI) >1/h, according to the criteria of the 
American Academy of Sleep Medicine
33), but there have been 
different criteria for childhood OSAS such as apnea index >1/h or 
AHI ≥1.5/h in several studies
1, 2, 4, 34). This does not mean that every 
child with an AHI ≥1.5/h will benefit from treatment
29-32). There 
is good consensus that moderate to severe PSG abnormality (AHI 
≥5) should be treated with T&A
1, 32, 35). However, for mild PSG 
abnormality, T&A is controversial and should depend on clinical 
symptoms and physical examination
1, 2, 29-32). 
Gozal
35, 36) suggested his criteria for diagnosis of pediatric 
OSA that requires treatment, like Jones criteria for the diagnosis 
of rheumatic fever, which included a combination approach 
of nocturnal PSG derived cut-off, and the presence of specific 
symptoms and measurable outcomes (biomarker, functional 
measures, etc.) (Table 2). It is not validated and revised con-
tinuously.
2)  Age, when to treat 
The age limit for T&A may be related to fear about more 
frequent upper airway infections and postoperative complications. 
Children under 3 years old had more postoperative complications
1, 2, 
28, 37).
OSAS occurs in children of all ages but peaks between 2 and 
8 years, coinciding with the peak age of lymphoid hyperplasia
8). 
Usually, children over 3 years or >15 kg could be operated without 
respiratory complications
28). However, T&A can be performed 
in the presence of severe airway obstruction without any age 
restriction. Moreover, age is not a contraindication for T&A if 
OSA is present
37, 38). Moreover, younger children under 3 years 
of age would have more severe OSAS, and surgery in younger 
children even with craniofacial abnormalities, syndromic features, 
Table 1. Absolute Indications for Sleep Studies 
Syndromic
Young (<3 years)
Neurologic compromise
Cardiovascular compromise 
Coagulation abnormality 
Unreliable parent/caregiver history 
History and physical exam do not correlate 
Surgical treatment failure
Morbid obesity 
Table 2. Proposed Criteria for the Diagnosis of Pediatric Obstructive Sleep Apnea that Requires Treatment
35) 
Major Minor
Obstructive apnea and hypopnea index ≥2/h
Respiratory arousal index >2/h TST
Nadir SpO2 <90% 
Excessive daytime sleepiness
Academic difficulties
Hyperactive behaviors
Arterial blood pressure >85
th percentile
Enuresis
Obesity (BMI z score >1.67)
Adenoid ≥+2 and/or tonsil ≥+2
C reactive protein >0.4 μg/mL
HDL <40 mg/dL
LDL >80 mg/dL
Fasting insulin >20 μIL/mL
Elevated norepinephrine/creatinine ratio (85
th percentile)
Recurrent otitis media and/or s/p tympanostomy tube
>5 visits to primary care physician/year for respiratory symptoms
Adenoids >+1
Tonsils >+1 
Asthma and/or allergic rhinitis
Family history of OSAS
Nadir SpO2 >90% but <93%
Habitual snoring would be a mandatory indication, defined as the presence of loud snoring ≥3 nights per week). The presence of any of the 5 major criteria or of 
any the 3 major and 3 minor criteria should reliably indicate the presence of OSA that requires referral for treatmentKorean J Pediatr 2010;53(10):872-879 • DOI: 10.3345/kjp.2010.53.10.872    875
and neurodevelopmental disorders had shown a more significant 
decrease in AHI after intervention than medical treatment
38). This 
validates the safety and efficacy of surgical treatment in higher-
acuity, young, tertiary-center patients with good respiratory 
investigation and support
37-39). 
3)  Tonsillectomy or adenoidectomy, or both?
Both the tonsils and the adenoid should be removed, even if 
one or the other appears to be more enlarged, because OSAS is 
caused by both structural and neuromuscular abnormality and 
the treatment should widen the airway as much as possible
1). There 
were anecdotal reports of the high persistence or recurrence of 
OSA if adenoidectomy or tonsillectomy alone was done instead of 
T&A
1). Nieminen found improvement of OSA after tonsillectomy 
in 73% of children with previous adenoidectomy
40). This suggests 
that adenoidectomy alone was insufficient. However, tonsillectomy 
alone is recommended for velopharyngeal incompetence such as 
submucous cleft palate
1). 
4) Outcome 
The results of published data on success rate of T&A in curing 
OSA are highly variable, ranging from 24%
10) to 100%
11). A 
systematic review of all published series in 2006
11) reported an 
overall success rate of 82.9% for uncomplicated pediatric patients. 
In a recent meta-analysis of current literatures, the success rate 
was 66.3% when cure was defined as an AHI <1
13). In a recent 
multicenter retrospective study
12), only 27.2% of children nor-
malized their respiratory patterns during sleep as determined 
by the post-T&A PSG. Contrary to popular belief, these data 
demonstrate that pediatric sleep apnea is often not cured by T&A 
defined by PSG criteria, although there is a statistically significant 
AHI improvement in nearly all patients undergoing T&A
11). High-
risk groups of residual disease include patients with young or old 
age, morbid obesity, craniofacial syndrome, Down syndrome, 
neuromuscular disorders, and severe preoperative sleep apnea
9-13). 
Preoperative AHI and BMI percentile are important factors 
that should be considered in the diagnosis and treatment plan of 
pediatric patients
10, 12). Close postoperative follow-up to monitor for 
residual disease is important. 
For long-term outcome, there also appeared to be increased 
risk of snoring and desaturation on PSG 12 years later in children 
treated for OSA
25). 
 5) Risk of T&A, morbidity and mortality
T&A continues to be associated with significant morbidity. 
The perioperative complication rate was 8.8%, and the unplanned 
admission rate was 8.0%
28). Mortality of T&A can be as low as 1 in 
10,000-35,000
1, 16). Acute general complications of T&A include 
hemorrhage, respiratory decompensation, anesthetic complication, 
pain, and poor oral intake. Postoperative hemorrhage has been 
reported in up to 3-8%, higher in older children, and return 
to surgery has been reported in 0.8% to 1.8% of patients
28, 41). 
Respiratory complication is increased when T&A is undertaken 
for airway obstruction relative to other indications. Postoperative 
respiratory complications has been reported in 4.4-15.1% in overall 
T&A, increased up to 23-36% in routine OSA cases and 60% in 
urgently performed cases. These complications result from transient 
worsening of OSA secondary to postoperative edema and increased 
secretion, respiratory depression from anesthetic agents or the 
use of oxygen with a blunted hypoxic drive and the occurrence of 
postoperative pulmonary edema
28, 42). The major risk factors for 
post-operative respiratory complications in children include young 
age (2-3 years), high preoperative AHI, low nadir oxygen saturation 
(<70-80%), and the presence of concurrent medical problems 
(obesity, prematurity, cerebral palsy) or craniofacial disorders 
(Table 3). T&A is currently performed as an outpatient day-
surgery, but high-risk patients should be hospitalized for continuous 
cardiopulmonary/oxygen monitoring
38). Continuous positive airway 
pressure (CPAP) can be used in the perioperative period to stabilize 
patients before T&A and to treat postoperative complications
39, 41). 
Late complications of T&A may be naso  pharyngeal stenosis and 
velopharyngeal incompetence. Velo  pharyngeal incompetence is 
transient, and mostly resolves with time
1).
Tonsillotomy is less painful, but has a greater recurrence rate than 
tonsillectomy. Therefore, it should be avoided in SDB children with 
concomitant history of recurrent tonsillitis
1). 
2. Alternative Surgical Treatment 
1) Other soft tissue reduction procedures
An example of such procedures is radiofrequency ablation of the 
Table 3. Children at Risk for Respiratory Complications
Age <3 years 
Weight <15 kg
Failure to thrive (weight <5
th centile for age)
Obesity (BMI >2.5 SD) 
Genetic, craniofacial, neuromuscular, or nasopharyngeal abnormalities
Mucopolysaccharidosis and syndromes associated with difficult airway
Significant cormorbidity (congenital heart disease, chronic lung disease)
Severe OSA on PSG (AI >10, RDI >20, oxygen nadir <80%, central apnea 
>30% of RDI)
Cardiac complication of OSA  (e.g.,right ventricular hypertrophy)
Prematurity
Asthma
Recent respiratory infection876      YM Ahn • Treatment of obstructive sleep apnea in children
tongue base, which is only rarely undertaken in children, such as 
those with Down syndrome or other causes of macroglossia. 
(1) Septoplasty and turbinectomy 
With the increasing under  standing of the progression of allergic 
rhinitis to SBD and the interplay between nasal obstruction 
and facial mal-developmen, which further predisposes to OSA, 
maximizing nasal patency quickly and safely should be considered 
in children with SDB. Septoplasy or turbinectomy may improve 
nasal airflow in older children. Due to the impact on facial growth, 
concerns about violating cartilage growth centers in the septum, 
no direct treatment of nasal septum deviation can be performed 
in children, however, inferior turbinate reduction is another viable 
option in treatment of allergic rhinitis to improve nasal flow 
and decrease nasal resistance much faster than nasal steroidal 
medication in older children
1, 15, 42). 
(2) Uvulopalatopharyngoplasty (UVPP)
UVPP is a surgical procedure involving the excision of the uvula 
and posterior portion of the palate and tonsils, and trimming and 
reorientation of the tonsillar pillar. In adults, it has a success rate 
of approximately 50%. UVPP is not commonly performed in 
children, because most children with sleep apnea do not demon-
strate the redundant tissue found in adults. UVPP is reserved for 
children with abnormal upper airway neuromuscular tone, such as 
those with cerebral palsy or Down syndrome, and in obese children 
with high Mallampati scores or redundant lateral pharyngeal 
tissue
1, 43). 
(3) Lingual tonsillectomy
Enlargement of lingual tonsils is increasingly being recognized 
as a cause of OSA , especially in Down syndrome, obese children, 
residual OSA after T&A
44). In about 35%, previous T&A is 
associated with an increased risk of overgrowth of the lingual 
tonsils. Endoscopic-assisted coblation lingual tonsillectomy is an 
effective technique for the treatment of lingual tonsillar hypertrophy 
causing persistent OSA in some children. It is important to identify 
enlargement of the lingual tonsils as a cause of OSA because it 
is one of the surgically curable causes of OSA. Especially when 
symptom recurs after T&A, lingual tonsillar hypertrophy should 
be suspected
45).
2)  Craniofacial surgery
Craniofacial surgery is indicated in complex patients who do not 
tolerate CPAP or who would also benefit from the cosmetic effect 
of surgery, particularly those with craniofacial anomalies
1). 
3)  Tracheostomy
Finally, tracheostomy is reserved for children with cerebral palsy 
or severe craniofacial malformations who cannot be treated with 
other methods
1, 2). 
3. Orthodontic treatment 
An appropriate treatment of upper airway anatomic abnor-
malities must be achieved as early and as completely as possible. 
It is much easier to use orthodontic treatment in children than in 
adults
46) (Fig. 2).
1) Rapid maxillary expansion (RME)
RME is an orthodontic procedure that uses a fixed appliances 
with expansion screw anchored on selected teeth, causing skeletal 
expansion of the upper jaw by application of orthopedic force to 
the midpalatal suture in maxillary widening
46). The procedure 
consists of an active increase of the palatal transverse diameters 
by progressive opening of the midpalatal suture (1 mm/d) during 
10-20 days, followed by a fixed retention time of 6-12 months. 
Eventually, its indication was extended to OSA in children with or 
without T&A
47). 
2) Mandibular distraction procedures and/or mandibular 
midline osteotomy
Distraction osteogenesis consists of slowly moving the mandible 
or midface in the direction desired by using a distraction device. It 
can be performed in children with severe micrognathia, including 
infants with Pierre Robin syndrome or hemifacial microsomia. 
Because the procedure take advantage of the rapid healing and 
capacity of growth in the pediatric skeleton, osteotomy with 
distraction of bone is widely accepted as the procedure of choice in 
the early management of airway obstruction caused by craniofacial 
Fig. 2. Maxillomandibular expansion for the treatment of sleep-
disordered breathing
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disproportion
48).
Medical therapies
1. Continuous positive airway pressure
Nasal positive airway pressure therapy to maintain upper 
airway patency is the main treatment of choice in adults with 
OSA. However, due to the different pathophysiology of childhood 
OSA, CPAP is reserved only for moderate to severe cases of OSA 
in children who are not eligible for T&A (noneligibility criteria 
includes neuromuscular diseases, obesity, severe bleeding tendency, 
craniofacial abnormality, idiopathic OSAS, and small tonsils and 
adenoids in adolescents)
1, 2, 49). CPAP has also been prescribed for 
children whose SBD persisted despite T&A. 
CPAP is not curative and often needs to be used indefinitely. 
Thus, compliance with long-term CPAP therapy is a major issue, 
and behavioral intervention is helpful
50). The remaining significant 
problems are related to the lack of optimal equipment for young 
children and frequent difficulties with regard to initial adaptation 
to the nasal mask and compliance to treatment. 
The most common side effects of CPAP use are nasal symptoms, 
including nasal congestion, rhinorrhea, dryness, and epistaxis, 
which are caused by the cooling and drying effect of CPAP, which, 
in turn, alters the nasal mucosa and impedes mucociliary clearance. 
Side effects, such as mask leak, skin irritation, and pressure sores, 
are generally mild and self-limited; however, the development of 
midface hypoplasia following prolonged use of nasal CPAP has 
been reported as a rare long-term complication
1, 2, 51). 
2. Antibiotics
Broad-spectrum antibiotics may offer temporary improvement
52). 
However, the use of antibiotics does not seem to obviate the need 
for surgery in most cases with adenotonsillar hypertrophy.
3. Anti-inflammatory Therapies
Upper airway inflammation is an important component of SDB 
in children. Chronic snoring causes repetitive vibration of upper 
airway soft tissues, inducing mechanical stress resulting in upper 
airway inflammation. Moreover, chronic systemic inflammation 
with SDB may contribute to upper airway inflammation. Such 
understanding has generated new therapeutic concepts in children 
with SDB. Nasal corticosteroids exert lympholytic action to treat 
inflammation and upper airway edema
53). Nasal fluticasone for 
6 weeks significantly decreased both adenoid size and AHI
53). 
In an open-labeled study, the leukotriene receptor antagonist 
montelukast was found to be clinically effective in reducing disease 
severity in children with mild OSA
54). In a subsequent study, a 
combination of intranasal steroids and leukotriene modifier for 12 
weeks was found to be useful in children with residual OSA after 
adenotonsillectomy
55). However, there was no long-term follow-up 
result more than 12 weeks after discontinuation of the medication. 
4. Weight Loss
Weight loss is recommended for all obese children
1, 56). After 
T&A, even obese children with OSA will demonstrate increase in 
weight gain
57). After treatment of OSA, initial severe OSA, obesity, 
and those with a positive family history of OSA, initial high BMI, 
and African-American race, Mallampati score, and have other 
anatomical abnormalities of upper airway confer an independent 
increased risk for recurrence or persistence of SDB after T&A
9-
13). This implies that good weight control is important after 
surgical treatment. Postoperative PSG and CPAP are frequently 
recommended after T&A in obese children. Bariatric surgery is an 
effective weight reduction treatment for morbidly obese adults and 
children with severe apnea who failed other treatments. 
5. Oral Appliance
Tongue retraining or mandibular repositioning devices are widely 
used in adults with OSA to increase the oropharyngeal space, but 
most are cumbersome and poorly tolerated by children
58).
6. Supplemental Oxygen
Supplemental oxygen abolishes desaturation episodes associated 
with OSA, but it does not treat the underlying obstruction and may 
worsen hypoventilation
59). If supplemental oxygen is considered in 
SDB children with severe desaturation, it must be used for a few 
days only, while awaiting urgent T&A, and should be monitored 
for ETCO2. 
7. Environmental Control 
There is high prevalence of allergy in children with OSA. Passive 
smoking is associated with snoring. Thus avoidance of allergens 
and cigarette smoking would help. If allergic rhinitis coexists, nasal 
corticosteroid as well as decongestant and immunotherapy are of 
value
1, 42).
Follow Up
All children should be reevaluated clinically after surgery. 
Significant improvement may occur soon after surgery and, 
traditionally, OSA improves 6-8 weeks after T&A
28). Those 
with severe OSA preoperatively continue to have risk factors for 878      YM Ahn • Treatment of obstructive sleep apnea in children
persistent OSA and thus require postoperative PSG
9, 10). Adenoidal 
recurrence may occur, especially in very young children. If children 
develop a recurrence of OSA symptoms, lateral PNS X-ray or 
direct visualization of the adenoid by endoscopy could check the 
adenoidal regrowth. Revision adenoidectomy is required. Adhesion 
and contraction of posterior pharyngeal wall were sometimes 
found
1, 28). 
Conclusion 
OSA in children is a frequent disease with a 1-4% prevalence 
rate. It imposes significant morbidity, causing neurobehavioral, 
cardiovascular, and endocrine complications. The impairment 
of nasal breathing with increased nasal resistance has a well-
documented negative impact on early childhood maxillomandi-
bular development, making the upper airway smaller and might 
lead to adult OSA after puberty. Optimal diagnostic methods and 
criteria are still being defined.
T&A should be considered a first-line therapy. For the majority 
of children with OSA, T&A improved upper airway obstructive 
sign and symptoms, quality of life, and behavioral and cognition 
problems, and decreased polysomnographic abnormality. However, 
recent published data on the success rates of T&A in curing 
pediatric OSAS are highly variable. Close postoperative follow-up to 
monitor for residual disease is equally important. Parents should be 
informed about the weight gain after T&A, and reduction of body 
weight is considered primarily for obese children. Management 
with ongoing CPAP therapy and/or other surgical interventions 
and anti-inflammatory therapies are also considered. Initially for 
severe cases, multidisciplinary team approach is recommended to 
plan the optimal therapy .  
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